This inventor holds 1 USPTO granted patent. Top assignee: National University Corporation Kumamoto University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Tomoe Kusayanagi: Innovator in Vascular Disorder Treatment
Introduction
Tomoe Kusayanagi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of vascular disorders. His innovative approach has led to the development of a therapeutic agent that addresses critical health issues.
Latest Patents
Kusayanagi holds a patent for a therapeutic agent aimed at treating vascular disorders caused by excessive synthesis and secretion of type IV collagen protein from vascular endothelial cells. The patent includes several key components: a therapeutic agent for vascular disorders, a pharmaceutical composition for treatment, and an agent that inhibits excessive synthesis of type IV collagen protein, all containing sirolimus as an active ingredient. This patent represents a significant advancement in the treatment of vascular conditions.
Career Highlights
Kusayanagi is affiliated with the National University Corporation Kumamoto University, where he conducts research and develops innovative solutions for medical challenges. His work has garnered attention for its potential to improve patient outcomes in vascular health.
Collaborations
Kusayanagi collaborates with esteemed colleagues, including Takumi Era and Sayaka Watanabe. Their combined expertise enhances the research and development efforts in the field of vascular disorders.
Conclusion
Tomoe Kusayanagi's contributions to the treatment of vascular disorders through his innovative patent highlight the importance of research and collaboration in advancing medical science. His work continues to pave the way for new therapeutic options in healthcare.